Related Experiment Video

Updated: Jun 23, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

Emerging treatments for retinopathy of prematurity

Iason S Mantagos1, Deborah K Vanderveen, Lois E H Smith

  • 1Department of Ophthalmology, Children's Hospital Boston, Boston, MA 02115, USA.

Seminars in Ophthalmology
|April 18, 2009
PubMed

Insights

Retinopathy of prematurity (ROP) is a major cause of childhood blindness. Emerging treatments focus on targeting growth factors like VEGF and IGF-1, and omega-3 fatty acids to prevent vision loss.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Medicine

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of preventable childhood blindness.
  • Increased survival rates of premature infants have led to a rise in ROP cases.
  • Current ROP management includes oxygen monitoring, retinal ablation (cryotherapy/laser), and surgery.

Purpose of the Study:

  • To review current and emerging treatments for retinopathy of prematurity.
  • To highlight advancements in understanding ROP pathogenesis.
  • To discuss novel therapeutic targets for ROP.

Main Methods:

  • Review of current clinical practices for ROP.
  • Analysis of recent research in angiogenesis and ROP.
  • Exploration of novel therapeutic pathways and nutritional interventions.

Main Results:

  • ROP remains a critical concern in neonatal eye care.
  • Angiogenesis research has identified key pathways involved in ROP.
  • Emerging treatments show promise in targeting specific molecular pathways.

Conclusions:

  • Novel treatments targeting VEGF and IGF-1 pathways offer new hope for ROP.
  • Dietary supplementation with omega-3 fatty acids is an emerging strategy.
  • Continued research is vital for improving ROP outcomes and preventing childhood blindness.

More Related Videos

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model07:43

Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model

Published on: August 5, 2021

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice07:46

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

Published on: October 6, 2023

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...